Is Pfizer Stock a Buy or Sell After Recent Dip? PFE Stock Analysis → How Biden has already won 2024 (From Porter & Company) (Ad) Hosted by MarketBeat StaffMarch 29, 2023 Share Share Play video for Is Pfizer Stock a Buy or Sell After Recent Dip? PFE Stock AnalysisDetailsGuestsIn this video, we discuss whether it's a good time for investors to buy into Pfizer's stock after its recent dip. The conversation covers Pfizer's past performance, the recent acquisition of Seagen, and its potential growth in the oncology field. Chris provides an objective analysis of Pfizer's fundamentals and earnings estimates for next year and discusses the market's current valuation.Stocks Mentioned in This EpisodeCompanyMarketRank™Current PriceDividend YieldP/E RatioPFEPfizer4.7583 of 5 stars$28.88+0.7%5.82%-481.25SGENSeagen0.2192 of 5 stars$228.740%N/A-57.04 Compare These Stocks Add These Stocks to My Watchlist Chris Markoch, GuestMarketBeat Contributor, MarketBeatChris Markoch is a freelance financial copywriter with over five years of experience covering various aspects of the financial markets. You may find his writing a little different than other stock articles you’ve read. And that’s OK with him. Chris doesn’t have a traditional finance background. What he does bring to the table is a strong business and marketing background having worked for agencies that serviced Fortune 500 companies. With that in mind, he isn’t overly impressed with what companies say, and more focused on what they do. And because buyer behavior dictates so much of what happens with a stock, Chris always keeps the end consumer close in mind. Chris has been writing for MarketBeat since 2018.Laycee Kluin, HostDigital Marketing Strategist, MarketBeatAs MarketBeat's Digital Marketing Strategist, Laycee helps with the marketing side of tasks including developing email campaigns, running the promotion of the MarketBeat products and exploring social media opportunities. She felt called to the Marketing industry because she enjoys collaborating with people and making connections. The University of Sioux Falls alum majored in Media Studies with minors in Communications and Spanish. Laycee brings a background in Financial Services Marketing.Previous VideoAll VideosNext Video Subscribe on YouTube Don't Miss a Video Subscribe to watch the latest stock market videos from MarketBeat. We empower investors to make better trading decisions by providing real-time financial data and objective market analysis. Subscribe on YouTube More From MarketBeatTrump’s Gift Could Unleash $51 Billion in New Wealthfrom Wealthpin Pro15 Stocks That Insiders Won't Stop Buyingfrom MarketBeatThe #1 Crypto That You Don’t Own… Yetfrom Crypto 101 Media10 Cheap Stocks Under $10 to Buy Now from MarketBeatBiden replacement revealed?from Paradigm Press20 High-Yield Dividend Stocks that Could Ruin Your Retirementfrom MarketBeat Recent Videos4 of the Best Stocks for Share BuybacksMicron Stock is the NVIDIA of MemoryNVIDIA’s Explosive Growth: Why the AI Leader’s Rally Isn’t Over Yet Featured Articles and Offers3 Stocks Insiders are Buying That Should be on Your RadarPosted May 28, 2024View 3 Stocks Insiders are Buying That Should be on Your RadarThe Only Energy Play You Should Be Looking AtFrom Wealthpin Pro(Ad)View The Only Energy Play You Should Be Looking AtDecker's Stock Surges Like NVIDIA Through $1,000 on Robust GrowthPosted May 29, 2024View Decker's Stock Surges Like NVIDIA Through $1,000 on Robust GrowthPure Storage Stock Spikes and Analysts are Jumping on BoardPosted May 30, 2024View Pure Storage Stock Spikes and Analysts are Jumping on BoardSalesforce Falls 25% Into A Once in a Lifetime OpportunityPosted May 30, 2024View Salesforce Falls 25% Into A Once in a Lifetime OpportunityMust-See: Elon’s New Invention is Absolutely InsaneFrom InvestorPlace(Ad)View Must-See: Elon’s New Invention is Absolutely Insane Search Videos: Search Videos Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Hosted by MarketBeat StaffMarch 29, 2023 Share Share Play video for Is Pfizer Stock a Buy or Sell After Recent Dip? PFE Stock AnalysisDetailsGuestsIn this video, we discuss whether it's a good time for investors to buy into Pfizer's stock after its recent dip. The conversation covers Pfizer's past performance, the recent acquisition of Seagen, and its potential growth in the oncology field. Chris provides an objective analysis of Pfizer's fundamentals and earnings estimates for next year and discusses the market's current valuation.Stocks Mentioned in This EpisodeCompanyMarketRank™Current PriceDividend YieldP/E RatioPFEPfizer4.7583 of 5 stars$28.88+0.7%5.82%-481.25SGENSeagen0.2192 of 5 stars$228.740%N/A-57.04 Compare These Stocks Add These Stocks to My Watchlist Chris Markoch, GuestMarketBeat Contributor, MarketBeatChris Markoch is a freelance financial copywriter with over five years of experience covering various aspects of the financial markets. You may find his writing a little different than other stock articles you’ve read. And that’s OK with him. Chris doesn’t have a traditional finance background. What he does bring to the table is a strong business and marketing background having worked for agencies that serviced Fortune 500 companies. With that in mind, he isn’t overly impressed with what companies say, and more focused on what they do. And because buyer behavior dictates so much of what happens with a stock, Chris always keeps the end consumer close in mind. Chris has been writing for MarketBeat since 2018.Laycee Kluin, HostDigital Marketing Strategist, MarketBeatAs MarketBeat's Digital Marketing Strategist, Laycee helps with the marketing side of tasks including developing email campaigns, running the promotion of the MarketBeat products and exploring social media opportunities. She felt called to the Marketing industry because she enjoys collaborating with people and making connections. The University of Sioux Falls alum majored in Media Studies with minors in Communications and Spanish. Laycee brings a background in Financial Services Marketing.Previous VideoAll VideosNext Video Subscribe on YouTube Don't Miss a Video Subscribe to watch the latest stock market videos from MarketBeat. We empower investors to make better trading decisions by providing real-time financial data and objective market analysis. Subscribe on YouTube More From MarketBeatTrump’s Gift Could Unleash $51 Billion in New Wealthfrom Wealthpin Pro15 Stocks That Insiders Won't Stop Buyingfrom MarketBeatThe #1 Crypto That You Don’t Own… Yetfrom Crypto 101 Media10 Cheap Stocks Under $10 to Buy Now from MarketBeatBiden replacement revealed?from Paradigm Press20 High-Yield Dividend Stocks that Could Ruin Your Retirementfrom MarketBeat